Viewing Study NCT04463004


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-01-05 @ 6:08 PM
Study NCT ID: NCT04463004
Status: COMPLETED
Last Update Posted: 2021-08-11
First Post: 2020-07-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
Sponsor: Virginia Commonwealth University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-02
Start Date Type: ACTUAL
Primary Completion Date: 2020-11-30
Primary Completion Date Type: ACTUAL
Completion Date: 2020-11-30
Completion Date Type: ACTUAL
First Submit Date: 2020-07-07
First Submit QC Date: None
Study First Post Date: 2020-07-09
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-08-04
Results First Submit QC Date: None
Results First Post Date: 2021-08-11
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-08-04
Last Update Post Date: 2021-08-11
Last Update Post Date Type: ACTUAL